Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Part of paid clinical trials in Rochester, New York.

Sponsor
University of Rochester
Study ID
NCT03706027
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • radiation therapy-3 fractions — DEVICE
    Radiation therapy given in a 3 fraction schedule (over 3 days). Total dose is 54 Grays.
  • Radiation therapy-5 fractions — DEVICE
    Radiation therapy given in 5 fractions (over 5 days). Total dose is 60 Grays.

Study Details

This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.

Key Dates

Start date
Dec 15, 2018
Status verified
Apr 2025
Primary completion
Nov 15, 2025
Completion
Nov 15, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Stereotactic body radiotherapy- 3 fractions
  • Active Comparator: Stereotactic body radiotherapy- 5 fractions

Primary Outcome Measure

frequency of grade 3 treatment related toxicities or higher [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
James P. Wilmot Cancer Center at University of Rochester Medical CenterRochesterNew York14642
Deepinder Singh, MD
[email protected]
585-275-5623

Find similar trials in Rochester, NY

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
James P. Wilmot Cancer Center at University of Rochester Medical Center· Rochester, NY

Related Studies